Bolton Securities’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Bolton Securities's DNA Position: Q3 2026 in Review
Bolton Securities reduced its Ginkgo Bioworks (DNA) stake by 97% in Q3 2026, selling an estimated $5.84K and leaving 25 shares worth $321. The position accounts for ﹤0.01% of the portfolio, ranked #2211.
Bolton Securities first reported a position in DNA in Q1 2025 and has held it in 7 quarters since. The position peaked at $21.6K in Q3 2025. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Bolton Securities held 25 shares of Ginkgo Bioworks worth $321 as of Q3 2026.
- Bolton Securities sold 717 Ginkgo Bioworks shares in Q3 2026, an estimated $5.84K.
- Ginkgo Bioworks made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #2211 holding.
- Bolton Securities first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 7 quarters since.
- Bolton Securities's Ginkgo Bioworks position peaked at $21.6K in Q3 2025.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.